All trials View full record on ClinicalTrials.gov
NCT07512362PHASE2NOT YET RECRUITING
Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
Eligibility check — Phoenix members
Phoenix members see for THIS trial:
- APOE genotype match
- Cognitive status fits inclusion
- Specific exclusions flagged
- Distance to nearest site
Sites
1 location
Start
2026-06-15
Interventions tested
- BIOLOGICALhuman Mesenchymal Stem Cells